BOB体育

Skip to main content

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

359 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2024

Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.

Diabetes, obesity & metabolism

鈥�

2024

The Impact of Polypill on Adherence and Cardiovascular Outcomes: A Comprehensive Systematic Review with Meta-Analysis.

Current cardiology reviews

鈥�

2023

Acute Myocardial Infarction Revealed by an Escape Rhythm in a Patient With Failed Sgarbossa Criteria.

JAMA internal medicine

鈥�

2023

Anticoagulation for atrial fibrillation using claims data - bigger is not always better.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

鈥�

2023

Association between statin exposure and diabetes incidence among privately-insured patients before and after applying a novel technique to control for selection bias.

The American journal of the medical sciences

鈥�